In a filing, GeneDx Holdings Corp revealed its Director Ryan Jason unloaded Company’s shares for reported $4.85 million on Aug 27 ’25. In the deal valued at $127.30 per share,38,072 shares were sold. As a result of this transaction, Ryan Jason now holds 103,284 shares worth roughly $13.37 million.
Then, Ryan Jason sold 1,150 shares, generating $149,093 in total proceeds. Upon selling the shares at $129.65, the Director now owns 11,904 shares.
Before that, Ryan Jason bought 39,222 shares. GeneDx Holdings Corp shares valued at $4,990,000 were divested by the Director at a price of $127.22 per share.
Piper Sandler initiated its GeneDx Holdings Corp [WGS] rating to an Overweight in a research note published on July 09, 2025; the price target was $110. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid May with a ‘”a Buy”‘ rating. Jefferies also remained covering WGS and has increased its forecast on May 09, 2025 with a “Buy” recommendation from previously “Hold” rating. Wells Fargo started covering the stock on August 28, 2024. It rated WGS as “an Equal weight”.
Price Performance Review of WGS
On Friday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock jump 0.38% to $129.49. Over the last five days, the stock has gained 0.64%. GeneDx Holdings Corp shares have risen nearly 266.31% since the year began. Nevertheless, the stocks have risen 68.48% over the past one year. While a 52-week high of $130.70 was reached on 08/29/25, a 52-week low of $28.86 was recorded on 05/08/25.
Levels Of Support And Resistance For WGS Stock
The 24-hour chart illustrates a support level at 128.03, which if violated will result in even more drops to 126.57. On the upside, there is a resistance level at 130.93. A further resistance level may holdings at 132.37.
How much short interest is there in GeneDx Holdings Corp?
A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on 2025-08-15, growing by 0.29 million shares to a total of 3.77 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 3.48 million shares. There was a rise of 7.75%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 10, 2024 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $43 price target.
